Ikena Oncology   Report issue

For profit Phase 1 Phase 2
Founded: Cambridge MA United States (2016)

Organization Overview

First Clinical Trial
2019
NCT04200963
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ikena Oncology